Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Therrien

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)Eric Therrien, Guillaume Larouche, Sukhdev Manku, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2009
N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)Martin Allan, Sukhdev Manku, Eric Therrien, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Discovery of 2H-Pyrrolo[3,4‑<i>c</i>]pyridin-3-one Derivatives as Type-III c‑MET Inhibitors Enabled by Free-Energy Perturbation CalculationsEric Therrien, Shulu Feng, Katherine Amberg-Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2009
Synthesis and evaluation of lysine derived sulfamides as histone deacetylase inhibitorsSukhdev Manku, Martin Allan, Natalie Nguyen, et al.
Journal of Medicinal Chemistry|August 5, 2005
Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimeticsStephen Hanessian, Hongying Yun, Yihua Hou, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2015
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitorsEric Therrien, Guillaume Larouche, Natalie Nguyen, et al.
Journal of Medicinal Chemistry|December 13, 2024
<i>In Silico</i> Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal InjuryH Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2008
Sulfamides as novel histone deacetylase inhibitorsAmal Wahhab, David Smil, Alain Ajamian, et al.
Journal of Medicinal Chemistry|December 12, 2024
Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an <i>In Silico</i> Enabled Drug Discovery PlatformHideyuki Igawa, Zef A Konst, Eric Therrien, et al.
Journal of Medicinal Chemistry|September 29, 2023
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid TumorsAlexander M Taylor, Bret R Williams, Fabrizio Giordanetto, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)Eric Therrien, Guillaume Larouche, Sukhdev Manku, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2009
N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)Martin Allan, Sukhdev Manku, Eric Therrien, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Discovery of 2H-Pyrrolo[3,4‑<i>c</i>]pyridin-3-one Derivatives as Type-III c‑MET Inhibitors Enabled by Free-Energy Perturbation CalculationsEric Therrien, Shulu Feng, Katherine Amberg-Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2009
Synthesis and evaluation of lysine derived sulfamides as histone deacetylase inhibitorsSukhdev Manku, Martin Allan, Natalie Nguyen, et al.
Journal of Medicinal Chemistry|August 5, 2005
Structure-based design, synthesis, and memapsin 2 (BACE) inhibitory activity of carbocyclic and heterocyclic peptidomimeticsStephen Hanessian, Hongying Yun, Yihua Hou, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2015
Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitorsEric Therrien, Guillaume Larouche, Natalie Nguyen, et al.
Journal of Medicinal Chemistry|December 13, 2024
<i>In Silico</i> Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal InjuryH Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2008
Sulfamides as novel histone deacetylase inhibitorsAmal Wahhab, David Smil, Alain Ajamian, et al.
Journal of Medicinal Chemistry|December 12, 2024
Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an <i>In Silico</i> Enabled Drug Discovery PlatformHideyuki Igawa, Zef A Konst, Eric Therrien, et al.
Journal of Medicinal Chemistry|September 29, 2023
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid TumorsAlexander M Taylor, Bret R Williams, Fabrizio Giordanetto, et al.
Pageof 3